Related references
Note: Only part of the references are listed.Sustainability Challenges and Opportunities in Oligonucleotide Manufacturing
Benjamin Andrews et al.
JOURNAL OF ORGANIC CHEMISTRY (2021)
Stereochemistry Enhances Potency, Efficacy, and Durability of Malat1 Antisense Oligonucleotides In Vitro and In Vivo in Multiple Species
Michael Byrne et al.
TRANSLATIONAL VISION SCIENCE & TECHNOLOGY (2021)
Antisense technology: A review
Stanley T. Crooke et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
Trace-Level Determination of Acrylonitrile Generated in the Manufacturing Process of Oligonucleotides by Static Headspace Gas Chromatography with an Electron Impact(+) Mass Detector
Xun Guo et al.
ORGANIC PROCESS RESEARCH & DEVELOPMENT (2021)
Variant-selective stereopure oligonucleotides protect against pathologies associated with C9orf72-repeat expansion in preclinical models
Yuanjing Liu et al.
NATURE COMMUNICATIONS (2021)
Antisense technology: an overview and prospectus
Stanley T. Crooke et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Synthesis of fully protected trinucleotide building blocks on a disulphide-linked soluble support
Ruth Suchsland et al.
RSC ADVANCES (2021)
Understanding the effect of controlling phosphorothioate chirality in the DNA gap on the potency and safety of gapmer antisense oligonucleotides
Michael E. Ostergaard et al.
NUCLEIC ACIDS RESEARCH (2020)
Unlocking P(V): Reagents for chiral phosphorothioate synthesis
Kyle W. Knouse et al.
SCIENCE (2018)
The chemical evolution of oligonucleotide therapies of clinical utility
Anastasia Khvorova et al.
NATURE BIOTECHNOLOGY (2017)
Control of phosphorothioate stereochemistry substantially increases the efficacy of antisense oligonucleotides
Naoki Iwamoto et al.
NATURE BIOTECHNOLOGY (2017)
UnyLinker dimer impurity characterization and process improvement
Joshua L. Brooks et al.
TETRAHEDRON LETTERS (2017)
The Medicinal Chemistry of Therapeutic Oligonucleotides
W. Brad Wan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Synthesis of PS/PO-chimeric oligonucleotides using mixed oxathiaphospholane and phosphoramidite chemistry
Ewa Radzikowska et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2015)
Stereochemical bias introduced during RNA synthesis modulates the activity of phosphorothioate siRNAs
Hartmut Jahns et al.
NATURE COMMUNICATIONS (2015)
The Chemical Synthesis of DNA/RNA: Our Gift to Science
Marvin H. Caruthers
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Principles of early drug discovery
J. P. Hughes et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Solid-Phase Synthesis of Stereoregular Oligodeoxyribonucleoside Phosphorothioates Using Bicyclic Oxazaphospholidine Derivatives as Monomer Units
Natsuhisa Oka et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
UnyLinker: An efficient and scaleable synthesis of oligonucleotides utilizing a universal linker molecule: A novel approach to enhance the purity of drugs
Vasulinga T. Ravikumar et al.
ORGANIC PROCESS RESEARCH & DEVELOPMENT (2008)
Simple and efficient solution-phase synthesis of oligonucleotides using extractive work-up
Martijn C. de Koning et al.
ORGANIC PROCESS RESEARCH & DEVELOPMENT (2006)
Synthesis of high-quality antisense drugs. Addition of acrylonitrile to phosphorothioate oligonucleotides: Adduct characterization and avoidance
DC Capaldi et al.
ORGANIC PROCESS RESEARCH & DEVELOPMENT (2003)
Proton-block strategy for the synthesis of oligodeoxynucleotides without base protection, capping reaction, and P-N bond cleavage reaction
M Sekine et al.
JOURNAL OF ORGANIC CHEMISTRY (2003)
An oxazaphospholidine approach for the stereocontrolled synthesis of oligonucleoside phosphorothioates
N Oka et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2003)
Share Paper
